DAX6.693-1,4%  Dow12.801-0,7%  Euro1,3200-0,7% 
ESt502.481-1,7%  Nas2.904-0,8%  Öl117,6-0,9% 
TDax769,9-0,4%  Nikkei8.947-0,6%  Gold1.721-0,5% 
Home > Aktien > Ligand Pharmaceuticals Aktie > Nachrichten zu Ligand Pharmaceuticals

Ligand Pharmaceuticals Aktie [WKN: 895777 / ISIN: US53220K2078]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyfinanzen
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime Push  IR-DatenAnleihen
handeln
Diese Aktie wird nicht mehr gehandelt

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur Ligand Pharmaceuticals Inc. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur Ligand Pharmaceuticals Inc

09.02.12Ligand to Present at the BIO CEO and Investor Conference on February 13
07.02.12Ligand Reports Fourth Quarter and Full Year 2011 Financial Results
07.02.12Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
02.02.12Ligand Presents Full Data from Successful Phase II Trial of Captisol-Enabled®, Propylene Glycol-Free Melphalan at the BMT Tandem Meetings
01.02.12Ligand to Report Fourth Quarter Results on February 7
04.01.12Ligand to Present at the Biotech Showcase Conference on January 10th
21.12.11Ligand Enters into Platform Captisol® License and Supply Agreements with Lilly
12.12.11Artio Global Investors Inc. Announces November Month-End Assets Under Management
12.12.11Ligand Announces Positive Preclinical Data on Small-Molecule GCSF Receptor Agonist at the 53rd Annual Meeting of the American Society of Hematology
12.12.11CSC Board Declares Quarterly Cash Dividend
07.12.11Ligand to Present at the Oppenheimer Healthcare Conference on December 14
08.11.11Ligand Pharmaceuticals Announces Third Quarter Results
08.11.11Globecomm Reports Fiscal 2012 First Quarter Financial Results
08.11.11Xerium Technologies Reports Third Quarter Results
07.11.11Ligand Announces Positive Preclinical Data on IRAK4 Program at the 2011 American College of Rheumatology Annual Scientific Meeting
07.11.11Save-the-Date: Ligand Hosting Promacta Panel Discussion on November 7
02.11.11Ligand Announces Successful Phase II Results for Captisol®-Enabled Propylene Glycol-Free Melphalan
24.10.11Save-the-Date: Ligand Hosting Promacta Panel Discussion on November 7
24.10.11AnyThing Technologies Media, Inc. and AMI Announce the Successful Launch of Joshua Blooms’ The Ultimate Answer is insideTM at the New Life Expo in NYC
19.10.11Ligand to Report Third Quarter Results on November 8
19.10.11Ligand Enters into Platform Captisol® License Agreement with SAGE Therapeutics
10.10.11Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn®
07.10.11Ligand to Present at the BioCentury NewsMakers Conference on October 21
26.08.11Ligand to Present at the Stifel Nicolaus Healthcare Conference on September 9
26.08.11Pioneer Natural Resources Declares Dividend on Common Shares
08.08.11Ligand Pharmaceuticals Announces Second Quarter Results
01.08.11Ligand to Report Second Quarter Results on August 8th
26.07.11Ligand Partner GlaxoSmithKline Receives Positive Data from Promacta® PIII ENABLE1 Study in Hepatitis C-Related Thrombocytopenia
22.06.11Ligand to Advance Clinical Development of Captisol-enabled®, Propylene Glycol-Free Melphalan for Multiple Myeloma
22.06.11Northern Virginia Regional Health Information Organization Inc. Launches Innovative Medication History Service
20.06.11Reminder: Ligand to Webcast Analyst and Investor Day on June 23 in New York City
20.06.11Ligand Enters into Captisol® Commercial Supply Agreement with Merck
06.06.11Dell Kicks Off Inaugural Dell Storage Forum, Welcoming Hundreds of Customers and Partners to Learn about Company’s World-Class Storage Technology
06.06.11Ligand Presents Phase IIa Data on Captisol®-Enabled, Propylene Glycol-Free Melphalan at ASCO 2011
06.06.11Ligand Presents Multi-Dose Phase I Data on Lead SARM Molecule LGD-4033 at the Endocrine Society Annual Meeting
03.06.11Ligand and The Medicines Company Agree to Worldwide License for Proprietary Captisol®-Enabled Intravenous Formulation of Clopidogrel
11.05.11Ligand to Webcast Analyst and Investor Day on June 23 in New York City
11.05.11ConocoPhillips Highlights Solid Results and Raises Concerns Over Un-American Tax Proposals at Annual Meeting of Shareholders
11.05.11GSLO: New Shipment of Volt Solar Chargers Arrives in U.S.
11.05.11GTSO President to Participate in International Rare Earth Summit in China

Anzeige

ANZEIGE

 
Wie bewerten Sie diese Seite?
schlecht sehr gut
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Telekurs. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon